OCUL
Ocular Therapeutix (OCUL)
$72
About Ocular Therapeutix (OCUL)
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Details
Daily high
$14.64
Daily low
$13.59
Price at open
$14.35
52 Week High
$16.44
52 Week Low
$5.78
Market cap
3.1B
Dividend yield
0.00%
Volume
3.2M
Avg. volume
3.8M
P/E ratio
-10.02
Ocular Therapeutix News
Details
Daily high
$14.64
Daily low
$13.59
Price at open
$14.35
52 Week High
$16.44
52 Week Low
$5.78
Market cap
3.1B
Dividend yield
0.00%
Volume
3.2M
Avg. volume
3.8M
P/E ratio
-10.02